Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 03 Nov 2025 for HAEMONETICS CORP, €6,266. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Roy Galvin: trading record in brief
Roy Galvin discloses dealings in Haemonetics Corp to SEC (Form 4). We count 10 filings; the first trade dates from 1 November 2022 and the latest from 31 October 2025.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 3 November 2025 with a share grant (€6,266) in Haemonetics Corp. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Roy Galvin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
145 shares@ US$50.0110.2% of flowCommon StockSEC:0000313143-25-000064:0
5,689 sharesCommon StockSEC:0001127602-25-017492:0
6,755 sharesCommon StockSEC:0001127602-25-015061:0
201 shares@ US$69.3820.3% of flowCommon StockSEC:0001127602-25-014938:0
161 shares@ US$71.4817.2% of flowCommon StockSEC:0001127602-24-026473:0
2,872 sharesCommon StockSEC:0001127602-24-016166:0
214 shares@ US$96.4930.9% of flowCommon StockSEC:0001127602-24-015882:0
160 shares@ US$86.3921.3% of flowCommon StockSEC:0001127602-23-026759:0
2,243 sharesCommon StockSEC:0001127602-23-015934:0
2,382 sharesCommon StockSEC:0001127602-22-024920:0
10 of 10 declarations
